See how Delfa is transforming

clinical research and driving

real results.

Weight Management & Type II Diabetes

How a leading U.S. site network used Delfa to randomize 101 patients in just one month

When you're running dozens of trials across multiple therapeutic areas, recruitment never stops. For the Director of Patient Engagement at one of the nation's largest independent site networks, every week brings new studies, new targets, and new deadlines. “In such a short space of time we have already become so dependent on Delfa,” she says. “I can't imagine life without you guys.”

This network is no stranger to high performance. With more than 30 active locations and a rapidly expanding portfolio, their team specializes in metabolic and endocrine studies. Therapeutic areas known for complex eligibility criteria and demanding patient follow-up. But despite having a dedicated in-house recruitment team, their biggest bottleneck was time.

“Our team was spending endless hours calling patients who never picked up,” the Director recalls. “We had amazing studies ready to schedule, but we couldn't get through to enough qualified participants quickly enough.”

36,600
Patient interactions
$42,000
Labor savings
97%
Patient satisfaction

In such a short space of time we have already become so dependent on Delfa. I can’t imagine life without you guys.

Director of Patient Engagement, Top 10 U.S. Site Network

Cardiovascular

How Delfa helped convert self-scheduled leads into randomized participants

Recruitment for cardiovascular studies is notoriously tough. Long screening windows, strict inclusion criteria, and time-sensitive follow-ups can stretch even the best teams to their limits.

For the VP of Patient Recruitment at one of the nation’s most established site networks, it was a familiar challenge. “We had strong top-of-funnel interest,” she recalls. “Patients were clicking through and even booking visits. But too many of those appointments were falling through before we could confirm eligibility.”

This was a long-running, complex cardiovascular study requiring detailed medical checks and multi-visit participation. Every missed connection meant lost time, missed targets, and wasted marketing spend.

253
Leads processed
66%
Successfully reached
7%
(25 patients) randomized

Delfa enabled us to grow the number of participants we could engage with, leading to more randomised participants and higher revenue.

VP of Patient Recruitment, Leading Cardiovascular Site Network

Elevate Clinical Research used Delfa to enroll 50% of their site target in just a week.

Machelle Stephens is busy. As Elevate's VP of Marketing and Patient Recruitment at any one time she is enrolling patients for 10+ studies, launching new campaigns, managing a team and still finding time to be a brilliant Mom to her toddler. "I have a lot going on." she laughs.

This is true for everyone at Elevate. With three locations today, the site network has ambitious expansion plans. "At Elevate we partner with patients and doctors to advance medical understanding and improve care. Better research means better health." says Devora Henderson the pioneering CEO and Co-founder behind Elevate "By the end of the year we want to be running 50 studies a year across 5 sites."

20
Hours a week saved per recruiter
125%
Site Enrollment Target
48
Hour Go Live

Delfa integrated into our systems within a week. By week two we were already live on our second study.

Machelle Stephens
VP Patient Recruitment